(19)
(11) EP 4 584 369 A1

(12)

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23863757.3

(22) Date of filing: 06.09.2023
(51) International Patent Classification (IPC): 
C12N 5/0783(2010.01)
A61P 35/00(2006.01)
A61K 35/17(2025.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 35/17; C12N 5/0638; C12N 2501/2302; C12N 2501/2315; C12N 2501/2321
(86) International application number:
PCT/US2023/032111
(87) International publication number:
WO 2024/054518 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 07.09.2022 US 202263374891 P
02.05.2023 US 202363499685 P

(71) Applicant: Nextvivo, Inc.
Palo Alto, California 94304 (US)

(72) Inventors:
  • LEUSHACKE, Marc
    Palo Alto, California 94304 (US)
  • JU, Jihang
    Palo Alto, California 94304 (US)
  • HYSENAJ, Lisiena
    Palo Alto, California 94304 (US)
  • MARGOLIN, Adam
    Palo Alto, California 94304 (US)
  • CHARTIER-COURTAUD, Cecile
    Palo Alto, California 94304 (US)

(74) Representative: Brand Murray Fuller LLP 
50 Eastcastle Street
London W1W 8EA
London W1W 8EA (GB)

   


(54) SYSTEMS AND METHODS OF ENHANCING TUMOR-REACTIVE IMMUNE POPULATIONS WITH ORGANOIDS